1,692
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Investigation of the colon-targeting, improvement on the side-effects and therapy on the experimental colitis in mouse of a resin microcapsule loading dexamethasone sodium phosphate

, , , , , , , , , & show all
Pages 1992-2002 | Received 05 Mar 2015, Accepted 27 Apr 2015, Published online: 26 May 2015

References

  • Amsel LP, Hinsvark ON. (1984). Recent advances in sustained-release technology using ion-exchange polymer. Pharm Technol 4:28–48
  • Anand V, Kandarapu R, Garg S. (2001). Ion-exchange resins: carrying drug delivery forward. Drug Discov Today 6:905–14
  • Barnes PJ. (2006). How corticosteroids control inflammation: quintiles prize lecture 2005. Br J Pharmacol 148:245–54
  • Blonski W, Buchner AM, Lichtenstein GR. (2014). Treatment of ulcerative colitis. Curr Opin Gastroenterol 30:84–96
  • Buchman AL. (2001). Side effects of corticosteroid therapy. J Clin Gastroenterol 33:289–94
  • Burton S, Washington N, Steele RJC, et al. (1995). Intragastric distribution of ion-exchange resins: a drug delivery system for the topical treatment of the gastric mucosa. J Pharm Phamacol 47:901–6
  • Chen Y, Burton MA, Codde JP, et al. (1992). Evaluation of ion-exchange microspheres as carriers for the anticancer drug Doxorubicin: in-vitro studies. J Pharm Pharmacol 44:211–15
  • Dahl R. (2006). Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med 100:1307–17
  • Das S, Subuddhi U. (2014). Controlled delivery of dexamethasone to the intestine from poly(vinyl alcohol)-poly(acrylic acid) microspheres containing drug-cyclodextrin complexes: influence of method of preparation of inclusion complex. RSC Adv 4:24222–31
  • De Cassan C, Fiorino G, Danese S. (2012). Second-generation corticosteroids for the treatment of Crohn's disease and ulcerative colitis: more effective and less side effects? Dig Dis 30:368–75
  • Deeb G, Becker BA. (1960). Absorption of sustained release oral amphetamine in rats. Toxicol Appl Farmacol 2:410–17
  • Dial EJ, Lichtenberger LM. (1986). Development of gastric-mucosal protection against acid in the rat-role of corticosteroids and prostaglandins. Gastroenterology 91:318–25
  • Dong K, Dong Y, You C, et al. (2014). Assessment of the safety, targeting, and distribution characteristics of a novel pH-sensitive hydrogel. Colloids Surf B Biointerfaces 123:965–73
  • Eroglu H, Kas HS, Oner L, et al. (2001). The in-vitro and in-vivo characterization of PLGA:L-PLA microspheres containing dexamethasone sodium phosphate. J Microencapsul 18:603–12
  • Freeman HJ. (2013). Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab. Ther Clin Risk Manag 9:451–6
  • Friend DR. (2005). New oral delivery systems for treatment of inflammatory bowel disease. Adv Drug Deliv Rev 57:247–65
  • Guo X, Chang RK, Hussain MA. (2009). Ion-exchange resins as drug delivery carriers. J Pharm Sci 98:3886–902
  • Ichikawa H, Fujioka K, Adeyeye MC, Fukumori Y. (2001). Use of ion-exchange resins to prepare 100 mm-sized microcapsules with prolonged drug-release by the Wurster process. Int J Pharm 216:67–76
  • Jaskari T, Vuorio M, Kontturi K, et al. (2000). Controlled transdermal iontophoresis by ion-exchange fiber. J Control Release 67:179–90
  • Jeong SH, Park K. (2008). Development of sustained release fast-disintegrating tablets using various polymer-coated ion-exchange resin complexes. Int J Pharm 353:195–204
  • Jewell DP. (1989). Corticosteroids for the management of Ulcerative-colitis and Crohns-disease. Gastroenterol Clin North Am 18:21–34
  • Kopacz DJ, Bernards CM, Allen HW, et al. (2003). A model to evaluate the pharmacokinetic and pharmacodynamic variables of extended-release products using in vivo tissue microdialysis in humans: bupivacaine-loaded microcapsules. Anesth Analg 97:124–31
  • Lennardjones JE. (1983). Toward optimal use of corticosteroids in Ulcerative-colitis and Crohns-disease. Gut 24:177–81
  • Li HQ, Xie WR, Strong JA, Zhang JM. (2007). Systemic antiinflammatory corticosteroid reduces mechanical pain behavior, sympathetic sprouting and elevation of proinflammatory cytokines in a rat model of neuropathic pain. Anesthesiology 107:469–77
  • Li M, Rouaud O, Poncelet D. (2008). Microencapsulation by solvent evaporation: state of the art for process engineering approaches. Int J Pharm 363:26–39
  • Lilienfield LS, Zapolski EJ. (1983). Controlled release dextromethorphan using advanced ionexchange technology. Curr Ther Res 33:692–702
  • Lundberg IE, Grundtman C, Larsson E, Klareskog L. (2004). Corticosteroids – from an idea to clinical use. Best Pract Res Clin Rheumatol 18:7–19
  • McCabe AJ, Dowhy M, Holm BA, Glick PL. (2001). Myeloperoxidase activity as a lung injury marker in the lamb model of congenital diaphragmatic hernia. J Pediatr Surg 36:334–7
  • Meier J, Sturm A. (2011). Current treatment of ulcerative colitis. World J Gastroenterol 17:3204–12
  • Mondino C, Ciabattoni G, Koch P, et al. (2004). Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children. J Allergy Clin Immunol 114:761–7
  • Monteleone G, Pallone F, Macdonald TT. (2011). Emerging immunological targets in inflammatory bowel disease. Curr Opin Pharmacol 11:640–5
  • Myou S, Fujimura M, Leff AR. (2004). Additive effect of cysteinyl leukotriene or thromboxane modifiers to inhaled corticosteroids in asthmatic patients. Allergol Int 53:211–17
  • Narisawa S, Nagata M, Danyoshi C, et al. (1994). An organic acid induced sigmoidal release system for oral controlled release preparations. Pharm Res 11:111–16
  • Patel SH, Rachchh MA, Jadav PD. (2012). Evaluation of anti-inflammatory effect of anti-platelet agent-clopidogrel in experimentally induced inflammatory bowel disease. Indian J Pharmacol 44:744–8
  • Samprasit W, Akkaramongkolporn P, Ngawhirunpat T, et al. (2013). Meloxicam taste-masked oral disintegrating tablet with dissolution enhanced by ion exchange resins and cyclodextrin. AAPS PharmSciTech 14:1118–28
  • Sohi H, Sultana Y, Khar RK. (2004). Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug Dev Ind Pharm 30:429–48
  • Thakral S, Thakral NK, Majumdar DK. (2013). Eudragit (R): a technology evaluation. Expert Opin Drug Deliv 10:131–49
  • Truelove SC, Witts LJ. (1954). Cortisone in Ulcerative colitis-preliminary report on a therapeutic trial. Br Med J 2:375–8
  • Turner D, Walsh CM, Steinhart AH, Griffiths AM. (2007). Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol 5:103–10
  • Wang WP, Guo X, Koo MW, et al. (2001). Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats. Am J Physiol Gastrointest Liver Physiol 281:G586–94
  • Yewale CP, Rathi MN, Kore GG, et al. (2013). Formulation and development of taste masked fast-disintegrating tablets (FDTs) of Chlorpheniramine maleate using ion-exchange resins. Pharm Dev Technol 18:367–76
  • Yu L, Li S, Yuan Y, et al. (2006). The delivery of ketoprofen from a system containing ion-exchange fibers. Int J Pharm 319:107–13
  • Zhao J, Cui Y, Wang AH, et al. (2011). Side effect reduction of encapsulated hydrocortisone crystals by insulin/alginate shells. Langmuir 27:1499–504

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.